If you're interested in being part of a clinical research study comparing an investigational drug (a drug that is not FDA-approved) to Coumadin®, please contact: Jay Garcia Novellus Research Sites 11160 Warner Ave, Suite 109 Fountain Valley, CA 92708 714-786-5155
Read More
We know that more men than women have atrial fibrillation, but that women have a higher rate of strokes and death. In fact, women account for about 61% of stroke deaths. Recent research at Rush University Medical Center identified nine specific gender differences between women and men who have atrial fibrillation. Those included that women …
Read More
If you're in the Detroit or Lansing, MI areas, please come join us for complimentary afib patient education forums this week. To learn more about each event, see the links below: Detroit Atrial Fibrillation Treatment Education Events - 9/23/2009 & 9/24/2009 Lansing, Michigan Atrial Fibrillation Patient Education Forum - 9/25/2009
Read More
Pat Robertson, Founder and Chairman of the Christian Broadcasting Network (CBN), recently had the Convergent Procedure for his atrial fibrillation, which in this case was accompanied by removal of his left atrial appendage. The Convergent Procedure for atrial fibrillation involves radio-frequency surgery followed by a radio-frequency catheter ablation, both of which are done in a …
Read More
There is a lot of big news coming out of the European Society of Cardiology (ESC) going on in Barcelona right now. Judging by attendance, this is probably the biggest cardiology event in the world. The big announcement for atrial fibrillation sufferers is the progress towards a replacement for Coumadin (warfarin) coming out of the …
Read More
A study of radio-frequency catheter ablation by the Agency for Healthcare Research and Quality (AHRQ) was one of the first government-mandated Comparative Effectiveness Research (CER) studies released. The report found that catheter ablation appears effective up to one year after the procedure, but more research is needed into longer-term success as well as the impact …
Read More
Sleep apnea is an important risk factor for atrial fibrillation. It is also associated with hypertension, coronary artery disease, heart failure, stroke, diabetes, and insulin resistance, all of which are risk factors for, or results of, atrial fibrillation. Now a new study has just reported that men between the ages of 40 and 70 who …
Read More
In Part 2 of StopAfib.org's video interview with Dr. Michael Argenziano, of NY-Presbyterian/Columbia University Medical Center, he discusses a trial that they are participating in that involves implanting a heart rhythm monitor after an atrial fibrillation procedure to see what a patient's rhythm looks like five, ten, and even twenty years later. Video Interview with …
Read More
In Part 1 of StopAfib.org's video interview with Dr. Michael Argenziano, he discusses the atrial fibrillation surgery done at NY-Presbyterian/Columbia University Medical Center. He covers the kind of surgery that he prefers for those with recent-onset paroxysmal atrial fibrillation as well as for those with one or more failed catheter ablations, for whom he favors …
Read More
We hear from so many afib patients every day about the trials, tribulations, and fears regarding being on amiodarone, or their refusal to take it. Since the FDA approved Multaq® (dronedarone) recently, the most frequent question I've fielded has been "When will Multaq® be available?" That happened this week, and the excitement they have shared …
Read More